Description
Diclak ID (Diclofenac) Tablets with Modified Release 150 mg. №20
Composition
Active Ingredient: Each tablet contains 150 mg of diclofenac with modified release.
Mechanism of Action
Diclofenac, the active ingredient in Diclak ID tablets, is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits the enzyme cyclooxygenase, reducing the production of prostaglandins involved in inflammation, pain, and fever.
Pharmacological Properties
The modified-release formulation of Diclak ID ensures sustained drug release, maintaining therapeutic levels in the body for extended periods, providing prolonged analgesic and anti-inflammatory effects.
Indications for Use
Indicated for: Relief of pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gout.
Contraindications
Do not use if: Allergic to diclofenac, have a history of gastrointestinal bleeding, or in the third trimester of pregnancy.
Side Effects
Common side effects may include gastrointestinal discomfort, headache, dizziness, and rash. Serious side effects such as gastrointestinal bleeding, cardiovascular events, and renal impairment may occur with prolonged or high-dose use.
Usage Instructions
Recommended Dosage: The usual dose is one tablet daily, swallowed whole with water, preferably with food. Follow the instructions provided by your healthcare provider and do not exceed the recommended dose.
Benefits Compared to Analogues
Diclak ID tablets with modified release offer prolonged pain relief and improved patient compliance compared to immediate-release formulations of diclofenac, providing a convenient once-daily dosing option for long-term pain management.
Suitable Patient Groups
Diclak ID tablets are suitable for adults including the elderly population for the management of chronic pain conditions. Consult a healthcare provider for pediatric use.
Storage and Shelf Life
Store Diclak ID tablets in a cool, dry place away from moisture and sunlight. Check the expiration date on the packaging and do not use expired tablets.
Packaging Description
Diclak ID tablets are available in a pack of 20 tablets, each containing 150 mg of diclofenac with modified release. The packaging is designed to maintain the integrity and stability of the tablets.
Clinical Evidence and Proven Effectiveness
Diclofenac has been shown in clinical studies to effectively manage various inflammatory conditions. Studies have demonstrated superior pain relief and functional improvement with diclofenac compared to placebo in osteoarthritis patients. Additionally, meta-analyses have supported the use of diclofenac for acute gout attacks, showing significant pain reduction and improved joint function.
